Shares outstanding increased 145.3%
Shares outstanding changed +145.3% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
120,142,811→294,758,7468 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →IVVD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 204.2%
Operating income changed -204.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$15.1M→-$45.8M3 prior comparisons
Working capital / assets moved 5239 bp higher
Working capital / assets changed +5239 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
16.64%→69.03%4 prior comparisons
Research & development increased 206.8%
Research & development changed +206.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$9.6M→$29.4M3 prior comparisons
Working capital changed across a low base
Working capital changed +918.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$14.8M→$151.1M4 prior comparisons
Operating margin moved 19298 bp lower
Operating margin changed -19298 basis points from the comparable as-filed period.
-127.78%→-320.76%1 prior comparisons
Capital expenditure changed across a low base
Capital expenditure changed +4536.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$11,000→$510,0004 prior comparisons
Current ratio increased 340.1%
Current ratio changed +340.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
1.33→5.874 prior comparisons
Selling, general & administrative increased 77.6%
Selling, general & administrative changed +77.6% from the comparable as-filed period.
$16.6M→$29.5M3 prior comparisons
Current liabilities decreased 30.2%
Current liabilities changed -30.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$44.5M→$31.0M4 prior comparisons
Trade receivables increased 29.0%
Trade receivables changed +29.0% from the comparable as-filed period.
$8.7M→$11.2M2 prior comparisons
Revenue increased 21.2%
Revenue changed +21.2% from the comparable as-filed period.
$11.8M→$14.3M1 prior comparisons
Capex / revenue moved 348 bp higher
Capex / revenue changed +348 basis points from the comparable as-filed period.
0.09%→3.57%1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.